This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
Developers are now working on new versions and improving the results of artificial intelligence.
Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation ...
Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
In November 2023, the estates of two now-deceased policyholders sued the US health insurer, United Healthcare, for deploying ...
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Pronto Translations today announced a new survey of businesses that examined preferences for translation services when ...
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...